Vaxdyn
PrivateLast Round
Series A
Sep 7, 2026
Total Funding Raised
$38M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Vaxdyn is a biotechnology company that develops vaccines to prevent infections caused by drug-resistant bacteria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vaxdyn Comparables
Compare Vaxdyn with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Immunethep | 86% | |
| Eli Lilly and Company | 83% | |
| Omniose | 82% |
Vaxdyn Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 7, 2026 | ||||
| Grant | Sep 2, 2024 | ||||
| Series A | Sep 2, 2024 | ||||
| Grant | Apr 22, 2024 | ||||
| Grant | Dec 2, 2021 | ||||
Seed | Mar 8, 2021 |
Vaxdyn Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series A, Grant |
| CARB-X | Grant |
| Arcano Partners | Series A |
| Biovance Capital Partners | Series A |
| Bionova Capital | Seed |
| EIC Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 7, 2026
$13M round led by Biovance Capital Partners.
- Aug 21, 2026
Monthly visitors increased 482% MoM, from 74 to 431.
Recent news
Latest coverage and updates
- receives_financingSep 7, 2026
Vaxdyn received financing of $12.8M in Series A on Sep 7th '26.
Vaxdyn Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Vaxdyn's valuation, stock price, and market status.
Is VAXDYN a public or private company?
VAXDYN is a private company.
What is the current stock price of VAXDYN?
VAXDYN is a private company with no public stock price. No recent secondary market data is available.
How much is VAXDYN worth (valuation)?
Valuation information for VAXDYN is not publicly available.
Can I buy VAXDYN stock?
VAXDYN shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VAXDYN's last funding round?
VAXDYN's most recent funding round was Grant on September 2, 2024.
Who are the main investors in VAXDYN?
Key investors in VAXDYN include EIC Fund.
Will VAXDYN IPO soon?
No public IPO plans have been announced for VAXDYN.
How can I track VAXDYN secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VAXDYN's secondary market activity and sign up for updates.